Elizabeth H.z. Thompson - 19 Jul 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, Research & Development
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
19 Jul 2022
Net transactions value
-$510,598
Form type
4
Filing time
20 Jul 2022, 18:19:33 UTC
Previous filing
11 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale $680 -8 -0.06% $85.02 12,968 19 Jul 2022 Direct F1
transaction HZNP Ordinary Shares Sale $6,973 -82 -0.63% $85.04 12,886 19 Jul 2022 Direct F1
transaction HZNP Ordinary Shares Sale $502,945 -5,917 -46% $85.00 6,969 20 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.